Since 2015 ESOI has been proudly offering educational webinars on various topics related to oncologic imaging. The live webinars are very successful, well visited and attract many international participants from all over the world.
In 2018, ESOI will offer 15 online lectures, comprising 3 webinars especially dedicated to young radiologists and, for the first time, 2 multidisciplinary webinars. Each webinar will last approximately 60 minutes (50 min. presentation and 10 min. for discussion/questions).
Registration to the first 2 online educational webinars will be offered to every interested participant free of charge. Participation in webinars 3-15 will be free of charge but only open to active ESOI members. Membership is offered to full and associate members for 30,00 € and to residents for 10,00 €.
We are pleased to announce that ESOI will offer a “Webinar Certificate”, starting in 2018. Everyone having attended at least 7 webinars in the current calendar year and correctly answered 70% of the related self-assessment questions will be issued this certificate at the end of the calendar year. The certificate will be personalised, individually stating each of the attended webinars, including short webinar descriptions.
How to obtain the certificate
- be/become an active ESOI member of the current calendar year
- attend at least 7 out of the 12 regular webinars
- residents have to attend additionally 2 out of the 3 young radiologist webinars
- complete and submit the self-assessment questions which will be following each webinar
- have at least 70% of all questions correctly answered
Please note that the self-assessment questions corresponding with the respective webinar will be shown on your computer directly after the webinar. As such you will only have this possibility to answer the questions. The questions will relate to the content of the respective webinar.
We do not recommend to follow the webinar in a group, as only the person registered and logged in to the respective webinar will be able to answer the self-assessment questions at the end and therefore recorded.
We kindly ask for your understanding that currently ESOI Educational Webinars are not CME accredited.
Upcoming ESOI Webinars 2018
2. Cross-sectional imaging of renal tumours
R. Pozzi Mucelli, Verona/IT
February 26, 2018
About the Presenter
Prof. Roberto Pozzi Mucelli graduated in Medicine from the University of Trieste with full marks and honours and conducted Visiting Research Programs at several universities in the United States. In 1994 he became a full professor of Radiology at the University of Trieste where he was also chairman of the Radiology Department between 2000 and 2004. Between 2004 and 2017 he chaired the department of radiology at the university of Verona. Meanwhile he was an invited speaker at many international and national meetings, performed for 11 years as Editor in Chief of “La Radiologia Medica”, the official journal of the Italian Society of Medical Radiology, and authored more than 350 papers on Diagnostic Radiology and textbooks on Computed Tomography, Magnetic Resonance Imaging and Pancreatic Imaging.
This lecture will address the features and the respective roles of CT and MRI in the detection, characterisation and staging of renal tumours.
Multidetector Computed Tomography (MDCT) is a fundamental imaging technique in the diagnosis of renal tumours: it is essential for confirmation and staging of lesions that are incidentally detected at US, and gives its contribution to the incidental detection of small renal tumors since about 1/3 of cases are diagnosed during a CT examination of the upper abdomen. MDCT also plays a role in the characterization of renal tumours, although some limitations still exist, especially for fat-poor angiomyolipoma and oncocytoma.
Magnetic resonance imaging (MRI) has nowadays comparable results with MDCT for detection, diagnosis and staging of renal masses. A careful MR technique has to be used to obtain both identification and characterization of renal tumours, and for the differential diagnosis with benign lesions.
- To describe the imaging features of tumors of the kidney
- To understand the radiological – pathological characteristics of renal tumors
- To discuss the differential diagnosis between benign and malignant renal tumors and the limitation of CT and MR imaging
This webinar will be offered free of charge to anyone interested. Registration will be accepted on a first come first serve base.
Please register via the following link: https://attendee.gotowebinar.com/register/3943884825439750659?source=Website
Young Radiologist's Webinar
3. Structured reporting in prostate cancer
D. Regge, Turin/IT
March 12, 2018
About the Presenter
Prof. Daniele Regge graduated in Medicine and Surgery from the University of Torino and specialised in Radiology right after. Since 1997, he is the Director of the Radiology Unit at the Candiolo Cancer Institute in Turin. Since 2009 he is also the Director of the Imaging and Data Processing Lab (IDP-Lab) at the same institute. In 2015, he started his associate professorship at the University of Torino. In the past 15 years his research has focused on the development of specialized computer software (i.e. CAD systems) and on the clinical validation of new imaging tests for cancer diagnosis. In addition, he published 174 papers on peer-reviewed international journals, including 156 original research papers, and organised 56 scientific meetings/courses. Between 2015 and 2017, Prof. Regge was the president of the European Society of Oncologic Imaging and he serves as a member of the ECR Oncologic Imaging Subcommittee 2019.
Multiparamentric (mp) MRI is becoming the frontline imaging examination for diagnosis and staging of prostate cancer. It consists in the combination of the following 3 MRI sequences: T2 weighted morphological sequence (T2w), diffusion weighted imaging (DWI) and dynamic contrast enhanced MRI (DCE). Combining the information from the 3 sequences allows identification of prostate cancer in 70 to 90% of patients. To promote global standardization and diminish variation in reporting of prostate mp MRI examination a classification system has been initially proposed in 2012, named PI-RADS. PI-RADS has been endorsed by the American College of Radiology and by radiological and urological societies and has become the universally accepted reporting system. In the following presentation we will review the current classification PI-RADv2, discuss its limitations and ambiguities and the proposed adjustments. Examples of mpMRI examinations with different PI-RAD scores will be shown. Examples of structured reporting templates and prostate sector maps for tumour localization will we reviewed in the final part of the lecture.
- To review indications of prostate mp-MRI
- To describe PI-RADSv2 reporting system and its limitations
- To show examples of reporting templates and to explain how to use sectors maps
This webinar will be offered free of charge to active ESOI members and all radiology residents interested. In case you are not an active ESOI or ESR member but a resident, please send the proof of your residency to email@example.com. Please register via the following link: https://attendee.gotowebinar.com/register/8456048549470611201?source=Website
Click on the iPad / iPhone to view the full webinar programmes for 2018.
Please note that the rogrammes are subject to possible modifications.
Past Webinars 2018
1. Rectal Cancer: a multidisciplinary approach to imaging
R. Beets-Tan, Amsterdam/NL; G. Beets, Amsterdam/NL; B. van Triest, Amsterdam/NL
Past Webinars 2017
1. Imaging of CNS tumours
P. Parizel, Antwerp/BE
2. Imaging and differential diagnosis of orbital tumours
U. Mueller-Lisse, Munich/DE
3. Imaging of lymphomas
M. Mayerhöfer, Vienna/AT
4. Imaging spectrum of primary and secondary mesenteric neoplasms
S. Nougaret, Montpellier/FR
5. Imaging of the treated pelvis: Pearls and pitfalls
E. Sala, New York/US
6. MR imaging of malignant diseases of the uterus
Y. Lakhman, New York/US
7. Practical advice in preparing successful scientific manuscripts
M. Reiser, Munich/DE
8. Imaging of recurrent prostate cancer
H. Vargas, New York/US
9. Bone metastases, how should we approach them with imaging?
T. Bäuerle, Erlangen/DE
10. PET-MRI in oncologic imaging - where do we stand?
V. Goh, London/UK
11. When to call a lesion an HCC?
G. Brancatelli, Palermo/IT
12. Current evidence for minimally invasive treatments in HCC
J. Ricke, Munich/DE
13. Diagnostic test studies: how I do it
M. Maas, Amsterdam/NL
14. Paediatric abdominal tumours
C. Granata, Genoa/IT
Past Webinars 2016
1. Staging of Rectal Cancer with MRI
R. Beets-Tan, Amsterdam/NL
2. Contrast-enhanced ultrasound-technical considerations and applications in oncologic imaging
D. Clevert, Munich/DE
M. Mack, Munich/DE
4. Whole body MRI in onology
V. Vandecaveye, Leuven/BE
5. Imaging of lung cancer: implications on management
L. Bonomo, Rome/IT
6. Imaging of biliary tract tumours
R. Manfredi, Verona/IT
7. Staging of ovarian cancer - providing a GPS to patient management
H. Hricak, New York/US
8. Role of MRI in the diagnosis and management of prostate cancer
H. Vargas, New York/US
9. Tailoring breast imaging surveillance to the woman´s risk
F. Gilbert, Cambridge/UK
10. Imaging of bone tumours
G. Guglielmi, Foggia/IT
11. RECIST, CHOI and beyond
M. D'Anastasi, Munich/DE
Past Webinars 2015
D. M.J. Lambregts, Maastricht/NL
A. Laghi, Latina/IT
G. Zamboni, Verona/IT
J. Futterer, Nijmengen/NL
F. Sardanelli, Milan/IT
W. Sommer, Munich/DE